BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2420107)

  • 1. A new synthetic retinoid, E-5166, augments epidermal beta-adrenergic adenylate cyclase response.
    Iizuka H; Watanabe M; Ohkawara A
    Acta Derm Venereol; 1985; 65(6):459-64. PubMed ID: 2420107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melittin-induced alteration of epidermal adenylate cyclase responses.
    Kajita S; Iizuka H
    Acta Derm Venereol; 1987; 67(4):295-300. PubMed ID: 2445146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activators of protein kinase C but not of phospholipase C modulate adenylate cyclase-responses of normal pig epidermis.
    Iizuka H; Takahashi H; Ishida-Yamamoto A; Hashimoto Y
    Epithelial Cell Biol; 1995; 4(1):35-41. PubMed ID: 8563794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of potent glucocorticoids augments epidermal beta-adrenergic adenylate cyclase response in vivo.
    Kajita S; Iizuka H; Hirokawa M; Tsutsui M; Mizumoto T
    Acta Derm Venereol; 1986; 66(6):491-6. PubMed ID: 2433868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of retinoids on the cyclic AMP system of pig skin epidermis.
    Iizuka H; Ohkuma N; Ohkawara A
    J Invest Dermatol; 1985 Oct; 85(4):324-7. PubMed ID: 2995498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1,25-dihydroxyvitamin D3 on adenylate cyclase and protein kinase C in pig epidermis.
    Koizumi H; Yasui C; Ohkawara A
    Acta Derm Venereol; 1991; 71(1):6-10. PubMed ID: 1676219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in response of psoriatic epidermis in cyclic AMP accumulation against certain adenyl cyclase agonists.
    Yoshikawa K; Mori N; Hadame K; Sakakibara S
    Acta Derm Venereol; 1980; 60(2):95-98. PubMed ID: 6155039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human skin epidermal adenylate cyclase systems: defective beta-adrenergic responsiveness in the involved epidermis of Darier's disease.
    Iizuka H; Ohkawara A; Ishibashi Y
    Curr Probl Dermatol; 1983; 11():45-58. PubMed ID: 6317292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera toxin- and forskolin-induced cyclic AMP accumulations of pig skin (epidermis). Modulation by chemicals which reveal the beta-adrenergic augmentation effect.
    Matsuo S; Iizuka H
    J Dermatol Sci; 1990 Jan; 1(1):7-13. PubMed ID: 1706621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of retinoids on DNA synthesis of pig epidermis: its relation to epidermal beta-adrenergic adenylate cyclase response and to epidermal superoxide dismutase activity.
    Hashimoto Y; Ohkuma N; Iizuka H
    J Dermatol Sci; 1990 Jul; 1(4):303-9. PubMed ID: 2151307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine-induced alteration of hormone-stimulated cyclic AMP synthesis in pig skin (epidermis).
    Iizuka H; Kishiyama K; Ohkuma N; Murata H; Ohkawara A
    J Invest Dermatol; 1984 Apr; 82(4):357-61. PubMed ID: 6323587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of the epidermal adenylate cyclase system: agonists and phorbol esters desensitize by independent mechanisms.
    Iizuka H; Asano K; Ito F; Tamura T; Takahashi H; Tsutsui M
    Biochim Biophys Acta; 1991 Jun; 1093(1):95-101. PubMed ID: 1646651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K; Pedone C; Brooker G
    Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of beta-adrenergic adenylate cyclase responsiveness of pig skin epidermis by suboptimal concentrations of epinephrine.
    Iizuka H; Kishiyama K; Ohkawara A
    J Invest Dermatol; 1983 Dec; 81(6):549-52. PubMed ID: 6315830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraviolet radiation augments epidermal beta-adrenergic adenylate cyclase response.
    Iizuka H; Kajita S; Ohkawara A
    J Invest Dermatol; 1985 May; 84(5):401-3. PubMed ID: 2987360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors, adenylate cyclase, depression, and lithium.
    Belmaker RH
    Biol Psychiatry; 1981 Apr; 16(4):333-50. PubMed ID: 6261845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the tumor promoter, phorbol 12-myristate, 13-acetate, on the epidermal adenylate cyclase system: evidence for adenylate cyclase-regulation by protein kinase C.
    Iizuka H; Sakai H; Tamura T
    J Invest Dermatol; 1989 Sep; 93(3):387-91. PubMed ID: 2549124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol ester-induced augmentation and inhibition of epinephrine-stimulated adenylate cyclase in S49 lymphoma cells.
    Johnson JA; Goka TJ; Clark RB
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):199-215. PubMed ID: 3020100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forskolin potentiation of cholera toxin-stimulated cyclic AMP accumulation in intact C6-2B cells. Evidence for enhanced Gs-C coupling.
    Barovsky K; Brooker G
    Mol Pharmacol; 1985 Dec; 28(6):502-7. PubMed ID: 3001496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of pig epidermal adenylate-cyclase responses by protein-synthesis inhibitors: its relation to glucocorticoid and colchicine effects.
    Iizuka H; Kishiyama K; Ohkuma N; Ohkawara A
    Arch Dermatol Res; 1985; 277(6):466-72. PubMed ID: 4051556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.